Wordt geladen...
Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
A recent prospective clinical trial provides further evidence that breast cancers arising in germline BRCA1 mutation carriers are highly sensitive to cisplatin chemotherapy. The potential significance of these data for the management of patients with BRCA1-related and BRCA2-related breast cancer is...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053124/ https://ncbi.nlm.nih.gov/pubmed/23146216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3332 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|